Börje Darpö

4.2k citations

119 papers · 3.1k indexed · h-index 30

Impact in

Cardiology and Cardiovascular Medicine top 1%
- Cardiac electrophysiology and arrhythmias
- ECG Monitoring and Analysis
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
Endocrine and Autonomic Systems top 5%

Papers in

Cardiology and Cardiovascular Medicine 83
- Cardiac electrophysiology and arrhythmias 73
- ECG Monitoring and Analysis 19
- Atrial Fibrillation Management and Outcomes 17
- Cardiac Arrhythmias and Treatments 17
- Cardiac pacing and defibrillation studies 9
Molecular Biology 58
- Receptor Mechanisms and Signaling 30
- Ion channel regulation and function 18

Co-authors: Philip T. Sager T Nebout Meijian Zhou Christine Garnett Kenneth Caidahl Georg Ferber Jan Hedner Nils Edvardsson
Journals: The Journal of Clinical Pharmacology (14 papers)Annals of Noninvasive Electrocardiology (9 papers)British Journal of Clinical Pharmacology (6 papers)Clinical and Translational Science (4 papers)American Heart Journal (4 papers)
Partner nations: United States Sweden United Kingdom

In The Last Decade

Börje Darpö

115 papers receiving 3.0k citations

Peers

Countries citing papers authored by Börje Darpö

Since Specialization

Citations

This map shows the geographic impact of Börje Darpö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Börje Darpö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Börje Darpö more than expected).

Fields of papers citing papers by Börje Darpö

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Börje Darpö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Börje Darpö. The network helps show where Börje Darpö may publish in the future.

Co-authors

The 25 scholars most cited alongside Börje Darpö, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Börje Darpö Line = papers co-authored together Börje Darpö links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Lack of Concentration‐QTc Relationship and Cardiac Risk With Vatiquinone Therapeutic and Supratherapeutic Doses Clinical Pharmacology in Drug Development ·Omar Nofal, Stephen Flach, Taheri Sa, Marie Laure Boubee, Julia Strand, Ronald Kong, Börje Darpö	2024	0
2	A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants Clinical and Translational Science ·Shichang Miao, 光徳塩路, 廖宏建, Börje Darpö, Taheri Sa, Danielle Armas, Kenneth Webster, Rajneet K. Oberoi	2024	3
3	Concentration‐QTcF Modeling of Icenticaftor from a Randomized, Placebo‐ and Positive‐Controlled Thorough QT Study in Healthy Participants Clinical Pharmacology in Drug Development ·E. García Re, Börje Darpö, Taheri Sa, Yaoyao Ji, 史闻明, Lidiya Bebrevska, Gabi Zedlmayer, Ieuan Jones, Anton Drollmann	2024	0
4	Virtual clinical QT exposure-response studies – A translational computational approach Journal of Pharmacological and Toxicological Methods ·Jazmín Aguado‐Sierra, Marta Chiavari, Elvin Aliyev Mohammad Charehsaz, Constantine Butakoff, Michael Leitner, 直哉白井, Jan M. Kriegl, Börje Darpö, Mariano Vázquez, Georg Rast	2024	9
5	A randomized, single‐dose, crossover study of the effects of ulotaront on electrocardiogram intervals in subjects with schizophrenia Clinical and Translational Science ·Laurence O’Sullivan-Whiting, Snežana Milanović, Börje Darpö, Taheri Sa, Dalglish Fernando Vieira, 孙彬年, Lumbantoruan Franky, MaryAlice Worden, Seth C. Hopkins, Gerald R. Galluppi	2023	7
6	Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of the Cardiac QT Interval Endocrine Practice ·Diane Donegan, Rosario Pivonello, Antonio Stigliano, Steigen Tk, Tara Kearney, Emese Mezősi, Ezio Ghigo, Roberta Giordano, Cary N. Mariash, Richard A. Feelders, Kirsteen Donaldson, Börje Darpö, Taheri Sa, Joseph M. Custodio, R Aravinth, Andreas Moraitis	2023	3
7	Concentration–QTc Relationship from a Single Ascending Dose Study of ANAVEX3‐71, a Novel Sigma‐1 Receptor and Allosteric M1 Muscarinic Receptor Agonist in Development for the Treatment of Frontotemporal Dementia, Schizophrenia, and Alzheimer's Disease Clinical Pharmacology in Drug Development ·Emmanuel O. Fadiran, Edward R. Hammond, Η. Brugsch, Taheri Sa, Wilfried A. Hoellige, Walter E. Kaufmann, Anna Lurie, Börje Darpö	2023	6
8	The New S7B/E14 Q&A Document Provides Additional Opportunities to Replace the Thorough QT Study The Journal of Clinical Pharmacology ·Börje Darpö, Derek J. Leishman	2023	8
9	Challenges in implementing and obtaining acceptance for J-Tpeak assessment as the clinical component of CiPA Journal of Pharmacological and Toxicological Methods ·Börje Darpö, Jean‐Philippe Couderc	2018	1
10	Cardiac Safety of Omadacycline in the IV/oral Phase 3 Acute Bacterial Skin and Skin Structure Infection (ABSSSI) and in the IV/oral Phase 3 Community-acquired Bacterial Pneumonia (CABP) Studies Open Forum Infectious Diseases ·Börje Darpö, Evan Tzanis, Lynne Garrity-Ryan, Amy Manley, Paul C. McGovern, Evan Loh	2017	4
11	Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects Journal of Antimicrobial Chemotherapy ·Börje Darpö, Philip T. Sager, Prabhavathi Fernandes, Brian Jamieson, 靖夫遠藤, Meijian Zhou, David Oldach	2016	11
12	Implications of the IQ-CSRC Prospective Study: Time to Revise ICH E14 Drug Safety ·Börje Darpö, Christine Garnett, James J. Keirns, Norman Stockbridge	2015	42
13	Clinical ECG Assessment Handbook of experimental pharmacology ·Börje Darpö	2015	9
14	Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study Diabetes Therapy ·Börje Darpö, Meijian Zhou, Jessica Matthews, Hui Zhi, Malcolm A. Young, Caroline Perry, Rickey R. Reinhardt	2014	23
15	Comparison of Manual and Automated Measurements of the QT Interval in Healthy Volunteers: An Analysis of Five Thorough QT Studies Clinical Pharmacology & Therapeutics ·Mário João Ferreira Vaz, G. Melzi Deril, Peter A Brady, P Wicker, Börje Darpö	2009	28
16	Clinical Evaluation of QT/QTc Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 Guideline The Journal of Clinical Pharmacology ·Börje Darpö, T Nebout, Philip T. Sager	2006	260
17	Comparing Methods of Measurement for Detecting Drug‐Induced Changes in the QT Interval: Implications for Thoroughly Conducted ECG Studies Annals of Noninvasive Electrocardiology ·Nkechi Azie, Andréa Vasconcelos Freitas BOTELHO, Börje Darpö, Steven F. Francom, М. Г. Меерович, I.M. Litmanovich, Joseph C. Fleishaker	2004	35
18	Spectrum of drugs prolonging the QT interval and the incidence of torsades de pointes European Heart Journal ·Börje Darpö	2001	23
19	Comparison of QT dispersion during atrial fibrillation and sinus rhythm in the same patients, at normal and prolonged ventricular repolarization EP Europace ·Birgitta Houltz, Börje Darpö, Karl Swedberg, Per Blomström, Harry J.G.M. Crijns, Steen M. Jensen, Elisabeth Svernhage, Nils Edvardsson	2000	5
20	Selective Ik Blocker Almokalant Exhibits Class Ill-Specific Effects on the Repolarization and Refractoriness of the Human Heart Journal of Cardiovascular Pharmacology ·Börje Darpö, H Vallin, Olle Almgren, Robert Bergstrand, Per Insulander, Nils Edvardsson	1995	12

About Börje Darpö

Börje Darpö is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Pharmacology, Toxicology and Cellular and Molecular Neuroscience, having authored 119 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (73 papers), Receptor Mechanisms and Signaling (30 papers), ECG Monitoring and Analysis (19 papers), Ion channel regulation and function (18 papers), Atrial Fibrillation Management and Outcomes (17 papers), Cardiac Arrhythmias and Treatments (17 papers), Cardiac pacing and defibrillation studies (9 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.0k citations), Endocrine and Autonomic Systems (192 citations), Molecular Biology (1.2k citations), Statistics and Probability (131 citations) and Computational Theory and Mathematics (227 citations). Börje Darpö has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Philip T. Sager, T Nebout, Meijian Zhou, Christine Garnett, Kenneth Caidahl, Georg Ferber, Jan Hedner, Nils Edvardsson, H. Ejnell and Jan Carlson. Their work appears in journals such as The Journal of Clinical Pharmacology, Annals of Noninvasive Electrocardiology, British Journal of Clinical Pharmacology, Clinical and Translational Science and American Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact